Tag: Breakthrough Therapy Designation

FDA Grants Priority Review for GSKโ€™s Bepirovirsen for Chronic Hepatitis B

The FDA has granted Priority Review to GSKโ€™s bepirovirsen for chronic hepatitis…

Harshad Hussain B

FDA Grants Breakthrough Therapy Designation to Novartisโ€™ Ianalumab for Sjรถgrenโ€™s Disease

The FDA has granted Breakthrough Therapy designation to Novartisโ€™ ianalumab for Sjรถgrenโ€™s…

ME Desk

Yeztugo by Gilead Gets FDA OK, Promises Easier HIV Prevention

Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA)…

ME Desk